AGP Picks
View all

AGP Executive Report

Last update: 7 hours ago

Digital Health Policy: Poland’s government is moving to restrict smartphone use in elementary schools nationwide from Sept. 1, banning phones during breaks and lessons while allowing exceptions for health monitoring, urgent parental contact, and education. Public Safety & Alcohol Harm Reduction: Warsaw has expanded a nighttime alcohol retail ban, cutting off shop, kiosk and petrol-station sales from 10pm to 6am to reduce alcohol-related disturbances; restaurants, bars and clubs stay exempt. Metabolic Health Research: Zealand Pharma presented new Phase 2 ZUPREME-1 data supporting petrelintide for chronic weight management, reporting clinically meaningful weight loss and improvements in cardiometabolic risk factors with low GI-related discontinuation. Clinical Education & Workforce: Thumbay International Pathway—Poland held a convocation marking its 10th year and 90 doctors trained in Poland after pre-clinical study in Ajman. Maternal Health Context: A new analysis highlights how maternal mortality remains a crisis, noting Poland’s lower maternal mortality ratio compared with the U.S. and emphasizing postpartum risk and mental health/substance use as key drivers. Sports Nutrition & Access: Polish tennis qualifier Maja Chwalińska’s French Open run spotlights the real costs athletes face and how sponsor support can cover basics like hotel bills.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Jun. 3, 2026

PharmStars graduates 10 digital health startups in spring 2026 cohort

EIN Presswire

fallback image
May 14, 2026

Clinical nutrition market forecast points to $21.28 billion by 2033

EIN Presswire

fallback image
Jun. 2, 2026

Thumbay International Pathway marks 10 years with 90 doctors in Poland track

EIN Presswire

fallback image
May 6, 2026

Bad Mom Podcast episode spotlights tech’s role in teen mental health crisis

EIN Presswire


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
The Effectiveness and Current Challenges of Home-Based Cardiac Telerehabilitation for Patients with Coronary Artery Disease: A Narrative Review

The Effectiveness and Current Challenges of Home-Based Cardiac Telerehabilitation for Patients with Coronary Artery Disease: A Narrative Review

Malvern man to drive to Polish-Ukrainian border loaded with aid

Malvern man to drive to Polish-Ukrainian border loaded with aid

Secrets of Death in Prehistoric Times.. Massive Cemetery Reveals Children’s Diseases

Secrets of Death in Prehistoric Times.. Massive Cemetery Reveals Children’s Diseases


fallback image
Jun. 4, 2026

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

GlobeNewswire, Inc.

fallback image
Jun. 3, 2026

Poland Bans Phones in Schools

MENAFN

fallback image
Jun. 3, 2026

PharmStars Announces Spring 2026 Graduates: 10 Digital Health Startups Complete PharmStars’ Pharma-focused Accelerator

EIN Presswire

fallback image
Jun. 3, 2026

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

GlobeNewswire, Inc.

fallback image
Jun. 1, 2026

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

GlobeNewswire, Inc.

fallback image
May 30, 2026

Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Ukraine's Zelensky Pledges Clear Timetable of Talks on EU Membership
Play
Ukraine's Zelensky Pledges Clear Timetable of Talks on EU Membership
YouTube video thumbnail: All Hands on Deck: the EU's €92 Million Bid for a Global Ocean Intelligence Network
Play
All Hands on Deck: the EU's €92 Million Bid for a Global Ocean Intelligence Network
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Protesters Clash With Police Over Trump Family-Linked Resort in Albania
Play
Protesters Clash With Police Over Trump Family-Linked Resort in Albania
YouTube video thumbnail: Putin Hosts Economic Forum as Ukraine War Rages
Play
Putin Hosts Economic Forum as Ukraine War Rages

Video Title

Sign up for:

Poland Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Sign up for:

Poland Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.